All In Biotech

Drug Trial Radar · NCT05636176

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Effects of Ziltivekimab Versus Placebo on Morbidity and Mortality in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation

Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 4,874 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

4,874

Actual

Start

May 8, 2023

Primary completion

Sep 3, 2026

Study completion Sep 3, 2026

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Dec 5, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get ziltivekimab or placebo. Participants will get study medicine for once-monthly injections either in a pre-filled syringe to inject the study medicine into a skinfold or a pen-injector to inject the study medicine into flat skin. The study is expected to last for up to 4 years. Participants will have up to 20 clinic visits. Participants will have to use a study app on their phone to record and share information about all their injections of study medicine and to fill in questionnaires.

Conditions

  • Heart Failure

Interventions

  • ZiltivekimabDrug

    Ziltivekimab subcutaneous (s.c.) injection in a pre-filled syringe or a pen-injector once-monthly for up to 4 years.

  • PlaceboDrug

    Ziltivekimab placebo s.c. injection in a pre-filled syringe or a pen-injector once-monthly for up to 4 years.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to First Occurrence of a Composite Heart Failure Endpoint Consisting of: Cardiovascular (CV) Death, Heart Failure (HF) Hospitalisation or Urgent HF VisitTime frame: From randomisation (month 0) to end of study (up to 48 months)

Locations

1,013 sites in 46 countries. Site status is shown where the registry gives one.

  • Advanced Cardiovascular, LLC

    Alexander City, Alabama

  • Eastern Shore Rsrch Inst, LLC

    Fairhope, Alabama

  • Heart Center Rsrch_Hunstville

    Huntsville, Alabama

  • Banner University Medical Ctr

    Phoenix, Arizona

  • Cardiology & Medicine Clinic

    Little Rock, Arkansas

  • InvivoCure -2

    Alhambra, California

  • National Heart Institute Cal

    Beverly Hills, California

  • Valley Clinical Trials

    Covina, California

  • Scripps Memorial Hospital La Jolla

    La Jolla, California

  • Purushotham & Akther Kotha MD, inc.

    La Mesa, California

  • VA Loma Linda Hlthcr Sys

    Loma Linda, California

  • Biopharma Clinical Research Services, LLC

    Los Angeles, California

  • VA Greater Los Angeles Hlthcare System

    Los Angeles, California

  • VAGrtrLosAngelesHlthcareSystem

    Los Angeles, California

  • Valley Clinical Trials, Inc.

    Northridge, California

  • UCI Health

    Orange, California

  • Stanford Univ School of Med

    Palo Alto, California

  • San Diego Cardiac Center

    San Diego, California

  • North America Research Institute

    San Dimas, California

  • Manshadi Heart Institute

    Stockton, California

  • Lundquist Inst-Biomed Innovtn

    Torrance, California

  • InvivoCure

    Van Nuys, California

  • Rocky Mountain Regional VAMC

    Aurora, Colorado

  • InvivoCure -2

    Denver, Colorado

  • S Denver Cardiology Associates

    Littleton, Colorado

  • Bridgeport Hospital

    Bridgeport, Connecticut

  • Cardiology Associates of Fairfield County

    Stamford, Connecticut

  • Pioneer Clinical Studies-Coral Gables

    Coral Gables, Florida

  • Nature Coast Clin Rsrch_Crystal River

    Crystal River, Florida

  • Integrative Research Assoc Inc

    Fort Lauderdale, Florida

  • New Generation of Medical Research

    Hialeah, Florida

  • Memorial Region Hosp_Hollywood

    Hollywood, Florida

  • E Coast Inst for Rsrch LLC_Jacksonville

    Jacksonville, Florida

  • Jacksonville Ctr for Clin Res

    Jacksonville, Florida

  • Baptist Health Research Institute

    Jacksonville, Florida

  • Baptist Health South Florida

    Miami, Florida

  • Pioneer Clinical Studies-Coral Gables

    Miami, Florida

  • NCH Research Institute

    Naples, Florida

  • Amavita Research Services, LLC

    North Miami Beach, Florida

  • Ocala Cardiovascular Research

    Ocala, Florida

Showing 40 of 1,013 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.